The titanium SpineJack implant is also available in a 5 mm diameter model to treat standard-sized vertebrae and a 4.2 mm diameter model to treat smaller vertebrae (notably thoracic vertebrae or other vertebrae in smaller patients).

Vexim CEO Bruce Grange said they are delighted to have obtained the CE mark for their 6.5 mm implant; it constitutes an essential milestone for rolling out their pre-sales strategy in Europe with a range of target populations.

In July 2009, the company signed an exclusive agreement with Stryker EMEA for distribution of the SpineJack in Germany, the UK, Austria and Ireland.